Mayo Clinic physician and researcher Dr. Abba Zubair's work combines two passions—medicine and space—for the benefit of ...

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

Bone and Cancer Working Group has released a comprehensive review detailing the often under-recognized impact of modern ...

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...

Scientists have identified a key molecular trigger that facilitates the production of red blood cells, potentially ...

The humble clove, known primarily for its distinctive warm flavor in holiday baking and traditional medicine cabinets, harbors remarkable secrets for ...

Mayo Clinic physician and researcher Dr. Abba Zubair’s work combines two passions — medicine and space — for the benefit of ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that ...

Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).

A new blood test tracking genetic changes in stem cells may predict leukemia risk and age-related diseases—potentially ...

Patients who underwent stem cell transplants (SCTs) involving mismatched unrelated donors (MMUDs) had a 1-year overall ...